The Bloodwise logo. Bloodwise appears in black text against a white background
Posted by

The NHS Spending Review: good news for the NHS and blood cancer patients

The Bloodwise logo. Bloodwise appears in black text against a white background
Posted by
25 Nov 2015

Government promise to set aside an additional £300 million to spend on cancer diagnostics and provide a cash injection of £6 billion next year to the NHS in England in timely boost for patients

Today the Chancellor outlined the government's spending plans for the next four years in the Spending Review promising that there will be as much as an additional £300 million set aside to spend on cancer diagnostics every year by 2020-2021 meaning that anyone suspected of cancer will be diagnosed within 28 days of being referred by a GP.

The Chancellor also confirmed that the science budget would be protected in real terms this Parliament and that the NHS in England will get an upfront cash injection of £6 billion next year as part of £10 billion added funding.

This comes as welcome news for patients and health care professionals alike after the recent de-listing of blood cancer drug indications from the Cancer Drugs Fund.

Our Patient Experience Director, Diana Jupp, said:

"We very much welcome the investment in the NHS which has been announced today, which includes £6bn delivered up-front next year. We know that the financial pressures on the NHS are becoming ever more acute so this immediate funding boost is welcome news for patients. The introduction of a 4 week target for cancer testing will allow patients to start treatment sooner and minimise the levels of stress and anxiety we know blood cancer patients experience when waiting for a diagnosis."

However there is more work that needs to be done to translate research breakthroughs into real patient benefit and this will be our focus going forwards. Diana added: 

"It’s also great news that the science budget will be protected in real terms this Parliament. However, it is essential these research breakthroughs are translated into patient benefit, so the focus now needs to be on accelerating access to the most effective, new medicines."

A more detailed breakdown of the Spending Review including a detailed summary of the implications on health is available on the BBC website.